 Seroprevalence HTLV-I/II infection male intravenous drug abusers Chicago serologic evidence HTLV-I/II infection male veterans inpatient drug treatment center Serum informed consent Serum specimens enzyme-linked immunosorbent assay antibody antibody HTLV-I/II sera reactive Western blot radioimmunoprecipitation assay HTLV-I/II Sixty-five patients positive HTLV-I/II antibodies positive antibodies additional patients seropositive antibodies viruses significant difference lymphocyte ratio seropositivity HTLV-I/II seropositivity black race age duration i.v drug use sexual intercourse lifetime history number sexual partners incidence diseases type drug needle-sharing practices